Starling Oncology STLN
NASDAQ STLN
$6.35 +0.13 (+2.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Starling Oncology (STLN) Asset Writedowns and Impairment (2022 - 2023)

Updated

Starling Oncology (STLN) reported Asset Writedowns and Impairment of $16.87 million for FY2023, up 69.6% from $9.94 million in FY2022.

Analysis

Starling Oncology (STLN) Asset Writedowns and Impairment (2022 - 2023) Analysis & Trends

  • Asset Writedowns and Impairment has a three-year compound annual growth rate of 31.0% (FY2020 to FY2023).
  • According to Business Quant data, Asset Writedowns and Impairment came in at $9.94 million in FY2022 and $7.5 million in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Starling Oncology 637.98 Mn 505.38 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 16.87 Mn
Dec 31, 2022 9.94 Mn
API Access

Starling Oncology Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=STLN&period=max&api_key=YOUR_API_KEY